Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human hybridoma suppressor factor acts selectively on CD4+ cells.

Y Tomita1, M M Dustoor, M K Cathcart

  • 1Department of Immunology and Cancer, Research Institute, Cleveland Clinic Foundation, OH 44106.

Immunopharmacology
|November 1, 1988
PubMed
Summary

Hybridoma suppressor factor (HSF) inhibits immunoglobulin and Interleukin-2 production. This immunosuppressive lymphokine specifically targets CD4+ cells, revealing a subset-specific mechanism of action in immune responses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemokine receptors on mononuclear phagocytes in the central nervous system of patients with multiple sclerosis.

Ernst Schering Research Foundation workshop·2002
Same author

CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis.

The American journal of pathology·2001
Same author

Calcium-independent phospholipase A(2) is required for human monocyte chemotaxis to monocyte chemoattractant protein 1.

Journal of immunology (Baltimore, Md. : 1950)·2001
Same author

Constitutive association of c-N-Ras with c-Raf-1 and protein kinase C epsilon in latent signaling modules.

The Journal of biological chemistry·2001
Same author

Lipoxygenases and atherosclerosis: protection versus pathogenesis.

Free radical biology & medicine·2000
Same author

In vitro knockout of human p47phox blocks superoxide anion production and LDL oxidation by activated human monocytes.

Journal of lipid research·2000

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • A human thymus cell hybridoma secretes hybridoma suppressor factor (HSF), an immunosuppressive lymphokine.
  • HSF is known to suppress polyclonal immunoglobulin (Ig) and Interleukin-2 (IL-2) production in peripheral blood mononuclear cells (PBMC).

Purpose of the Study:

  • To further analyze the mechanism of HSF-mediated suppression of Ig and IL-2 production.
  • To determine the specific cell subsets targeted by HSF.

Main Methods:

  • Utilized pokeweed mitogen (PWM)-stimulated PBMC cultures.
  • Investigated HSF activity in reconstituted cultures of CD4+ cells and non-T cells.
  • Assessed IL-2 production by CD4+ and CD8+ cells.
  • Evaluated Ig production suppression through preabsorption experiments with CD4+ and CD8+ cells.

Related Experiment Videos

Main Results:

  • HSF inhibited PWM-induced IL-2 production specifically in CD4+ cells, with no effect on CD8+ cells.
  • The suppressive activity of HSF on Ig production was completely abolished by preabsorption with CD4+ cells, but not CD8+ cells.
  • These findings indicate a subset-specific action of HSF.

Conclusions:

  • HSF exerts its immunosuppressive effects through a mechanism that specifically targets CD4+ T-cells.
  • The study elucidates a subset-specific action of HSF, contributing to the understanding of immune regulation.